Literature DB >> 21601106

More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis.

Robert C Bast, David R Spriggs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21601106     DOI： 10.1016/j.ygyno.2011.04.032

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  20 in total

1.  Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.

Authors:  Thapi Dharma Rao; Alberto Fernández-Tejada; Abram Axelrod; Nestor Rosales; Xiujun Yan; Sahityasri Thapi; Amy Wang; Kay J Park; Brandon Nemieboka; Jingyi Xiang; Jason S Lewis; Narciso Olvera; Douglas A Levine; Samuel J Danishefsky; David R Spriggs
Journal:  ACS Chem Biol       Date:  2017-06-28       Impact factor: 5.100

2.  Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents.

Authors:  Thapi D Rao; Nestor Rosales; David R Spriggs
Journal:  Mol Cancer Ther       Date:  2011-08-04       Impact factor: 6.261

Review 3.  Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy.

Authors:  Ignacio Romero; Robert C Bast
Journal:  Endocrinology       Date:  2012-03-13       Impact factor: 4.736

4.  [A preliminary study of retinoblastoma-related serum tumor markers].

Authors:  Zhi-Ping Liu; Ke-Ying Zhou; Li-Li Chen; Zhi-Hui Xiao; Yan-Zhao Chen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-03

5.  Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.

Authors:  Eleftherios P Diamandis; Robert C Bast; Phil Gold; T Ming Chu; John L Magnani
Journal:  Clin Chem       Date:  2012-11-30       Impact factor: 8.327

Review 6.  Emerging role of mucins in epithelial to mesenchymal transition.

Authors:  Moorthy P Ponnusamy; Parthasarathy Seshacharyulu; Imayavaramban Lakshmanan; Arokia P Vaz; Seema Chugh; Surinder K Batra
Journal:  Curr Cancer Drug Targets       Date:  2013-11       Impact factor: 3.428

7.  Detection and analysis of multiple biomarkers in ovarian cancer: clinical significance in diagnosis, treatment, and prognosis evaluation.

Authors:  Rui Ji; Yong Li; Chenyun He; Xinghua Zhu; Aiqin He; Yunyan Lu
Journal:  Gland Surg       Date:  2020-12

8.  Repopulation of ovarian cancer cells after chemotherapy.

Authors:  Carlos M Telleria
Journal:  Cancer Growth Metastasis       Date:  2013-02-18

9.  Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer.

Authors:  Shu-Ming He; Fuqi Xing; Hong Sui; Youming Wu; Yongli Wang; Dong Wang; Guanghui Chen; Zijing Kong; Shu-Feng Zhou
Journal:  Med Sci Monit       Date:  2011-11

Review 10.  MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Authors:  Mildred Felder; Arvinder Kapur; Jesus Gonzalez-Bosquet; Sachi Horibata; Joseph Heintz; Ralph Albrecht; Lucas Fass; Justanjyot Kaur; Kevin Hu; Hadi Shojaei; Rebecca J Whelan; Manish S Patankar
Journal:  Mol Cancer       Date:  2014-05-29       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.